Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR and C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in the West Siberian Region of Russia

Molecular Biology

Volumn 44, Issue 5, 2010, Pages 720-727

  Weiner, A S ^a,b   Boyarskih, U A ^b   Voronina, E N ^b   Selezneva, I A ^c   Sinkina, T V ^c   Lazarev, A F ^c   Petrova, V D ^c   Filipenko, M L ^b  

^a NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

breast cancer; folate metabolizing genes; meta analysis; Russian population

Indexed keywords

EID: 77957991657     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893310050067     Document Type: Article

References (37)

1. Willems P. J. 2007. Susceptibility genes in breast cancer: More is less? Clin. Genet. 72, 493-496.
2. Collaborative Group on Hormonal Factors in Breast Cancer. 2001. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet. 358(9291), 1389-1399.
3. Dunning A. M., Healey C. S., Pharoah P. D., et al. 1999. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 8(10), 843-854.
4. Choi S. W., Mason J. B. 2000. Folate and carcinogenesis: An integrated scheme. J. Nutr. 130(2), 129-132.
5. Zijno A., Andreoli C., Leopardi P., et al. 2003. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis. 24(6), 1097-1103.
6. Kekeeva O. V., Zhevlova A. I., Podistov Yu. I., Solov'eva Yu. V., Zaletaev D. V., Nemtsova M. V. 2006. Aberrant methylation of tumor suppressor genes and allelic imbalance in cervical intraepithelial neoplasia. Mol. Biol. 40, 194-199.
7. Zintzaras E., Giannouli S., Rodopoulou P., Voulgarelis M. 2008. The role of MTHFR gene in multiple myeloma. J. Hum. Genet. 53(6), 499-507.
8. Langevin S. M., Lin D., Matsuo K., et al. 2009. Review and pooled analysis of studies on MTHFR C677T poly morphism and esophageal cancer. Toxicol. Lett. 184(2), 73-80.
9. Ulvik A., Vollset S. E., Hansen S., et al. 2004. Colorectal cancer and the methylenetetrahydrofolate reductase 677C → T and methionine synthase 2756A → G polymorphisms: A study of 2168 case-control pairs from the JANUS cohort. Cancer Epidemiol. Biomarkers Prev. 13(12), 2175-1280.
10. Shrubsole M. J., Gao Y. T., Cai Q., et al. 2004. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev. 13(2), 190-196.
11. Lewis S. J., Harbord R. M., Harris R., Smith G. D. 2006. Meta-analysis of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl. Cancer Inst. 98(22), 1607-1622.
12. Cheng C. W., Yu J. C., Huang C. S., et al. 2008. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res. Treat. 111(1), 145-155.
13. Suzuki T., Matsuo K., Hirose K., et al. 2008. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis. 29(2), 356-362.
14. Lee S. A., Kang D., Nishio H., et al. 2004. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp. Mol. Med. 36(2), 116-121.
15. Deligezer U., Akisik E. E., Dalay N. 2005. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In vivo. 19(5), 889-893.
16. Ma E., Iwasaki M., Junko I., et al. 2009. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: A case-control study in Brazilian women. BMC Cancer. 9, 122.
17. Grieu F., Powell B., Beilby J., Iacopetta B. 2004. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. Anticancer Res. 24(5B), 3215-3219.
18. Le Marchand L., Haiman C. A., Wilkens L. R., et al. 2004. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 13(12), 2071-2077.
19. Forsti A., Angelini S., Festa F., et al. 2004. Single nucleotide polymorphisms in breast cancer. Oncol. Rep. 11(4), 917-922.
20. Langsenlehner U., Krippl P., Renner W., et al. 2003. The common 677C > T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res. Treat. 81(2), 169-172.
21. Justenhoven C., Hamann U., Pierl C. B., et al. 2005. One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol. Biomarkers Prev. 14(12), 3015-3018.
22. Campbell I. G., Baxter S. W., Eccles D. M., Choong D. Y. 2002. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. 4(6), R14.
23. Kotsopoulos J., Zhang W. W., Zhang S., et al. 2008. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res. Treat. 112(3), 585-593.
24. Martin Y. N., Olson J. E., Ingle J. N., et al. 2006. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 15(11), 2322-2324.
25. Xu X., Gammon M. D., Zhang H., et al. 2007. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis. 28(7), 1504-1509.
26. Stevens V. L., McCullough M. L., Pavluck A. L., et al. 2007. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomarkers Prev. 16(6), 1140-1147.
27. Lissowska J., Gaudet M. M., Brinton L. A., et al. 2007. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case-control study and meta-analyses. Int. J. Cancer. 120(12), 2696-2703.
28. Perelmuter V. M., Zavyalova M. V., Vtorushin S. V., Slonimskaya E. M., Kritskaya N. G., Garbukov E. Yu., Litvyakov N. V., Stacheeva M. N., Babyshkina N. N., Malinovskaya E. A., Denisov E. V., Grigorjeva E. S., Nazarenko M. S., Sennikov S. V., Goreva E. P., Kozlov V. A., Voevoda M. I., Maximov V. N., Belyavskaya V. A., Cherdyntseva N. V. 2008. Genetic and clinic-pathological characteristics of breast cancer in premenopausal and postmenopausal women. Usp. Gerontol. 21(4), 643-653.
29. Fetisova I. N., Dobrolyubov A. S., Lipin M. A., Polyakov A. V. 2007. Polymorphism in folate metabolism genes and human diseases. Vestn. Nov. Med. Tekhnol. 10(1), 91-96.
30. van der Put N. M., Gabreels F., Stevens E. M., et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62(5), 1044-1051.
31. Castro R., Rivera I., Ravasco P., et al. 2004. 5, 10-methylenetetrahydrofolate reductase (MTHFR) 677C T and 1298A C mutations are associated with DNA hypomethylation. J. Med. Genet. 41(6), 454-458.
32. Friso S., Choi S. W., Girelli D., et al. 2002. A common mutation in the 5. 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA. 99(8), 5606-5611.
33. Paz M. F., Avila S., Fraga M. F., et al. 2002. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 62(15), 4519-4524.
34. Jacob R. A., Gretz D. M., Taylor P. C., et al. 1998. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in post-menopausal women. J. Nutr. 128(7), 1204-1212.
35. DeVos L., Chanson A., Liu Z., et al. 2008. Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am. J. Clin. Nutr. 88(4), 1149-1158.
36. Qi X., Ma X., Yang X., et al. 2010. Methylenetetrahy-drofolate reductase polymorphisms and breast cancer risk: A meta-analysis from 41 studies with 16480 cases and 22388 controls. Breast Cancer Res. Treat. [Epub ahead of print]. http://www. ncbi. nlm. nih. gov/pubmed/20135343.
37. Zhang J., Qiu L. X., Wang Z. H., et al. 2010. MTHFR C677T polymorphism associated with breast cancer susceptibility: A meta-analysis involving 15260 cases and 20411 controls. Breast Cancer Res. Treat. [Epub ahead of print]. http://www. ncbi. nlm. nih. gov/pubmed/20135343.